20 miliardi di euro l’anno: i costi per il cancro in Italia – Prevenzione attiva, la vera arma vincente
We need an artificial intelligence tool that analyzes and integrates anamnestic information and data on genomic instability, gut dysbiosis, chronic inflammation, immune system deficiencies and, possibly, mitochondrial dysfunction. In addition, we need to develop a custom platform to store and handle customers’ data and results, and to integrate the information derived from the different modules considered – HELIXBALANCE, CYTOBALANCE, IMMUNEBALANCE, MICROBALANCE – all together in a single consistent tool, and possibly another one, that will be developed during the project. We will dedicate the entire WP1 to the development of this AI tool. It will comprise the following main activities: structuring the AI system; solid cancer predictive algorithm optimization; integration of mitochondrial dysfunction. WP2 will be strongly connected with WP1, from which it will collect the customer’s data needed for fine-tuning.
